Your payment is in progress...
  +1 (704) 266-3234

Global And China Chronic Kidney Disease Drugs Market Insights, Forecast To 2026

Published on: Sep 2020 | From USD $3900 | Published By: QY RESEARCH | Number Of Pages: 129

Chronic Kidney Disease Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Kidney Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Chronic Kidney Disease Drugs market is segmented into
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others

Segment by Application, the Chronic Kidney Disease Drugs market is segmented into
Hospitals
Specialty Clinics

Regional and Country-level Analysis
The Chronic Kidney Disease Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Chronic Kidney Disease Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Chronic Kidney Disease Drugs Market Share Analysis
Chronic Kidney Disease Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chronic Kidney Disease Drugs business, the date to enter into the Chronic Kidney Disease Drugs market, Chronic Kidney Disease Drugs product introduction, recent developments, etc.
The major vendors covered:
Keryx Biopharmaceuticals, Inc
Kissei Pharmaceutical Co., Ltd
AbbVie
GlaxoSmithKline
Sanofi
F. Hoffmann-La Roche Ltd
Pfizer
AstraZeneca
Amgen
Teva Pharmaceutical Industries

1 Study Coverage
1.1 Chronic Kidney Disease Drugs Product Introduction
1.2 Market Segments
1.3 Key Chronic Kidney Disease Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Chronic Kidney Disease Drugs Market Size Growth Rate by Type
1.4.2 ACE Inhibitors
1.4.3 Calcium Channel Blockers
1.4.4 Beta Blockers
1.4.5 Others
1.5 Market by Application
1.5.1 Global Chronic Kidney Disease Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Chronic Kidney Disease Drugs Market Size, Estimates and Forecasts
2.1.1 Global Chronic Kidney Disease Drugs Revenue 2015-2026
2.1.2 Global Chronic Kidney Disease Drugs Sales 2015-2026
2.2 Global Chronic Kidney Disease Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Chronic Kidney Disease Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Chronic Kidney Disease Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Chronic Kidney Disease Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Chronic Kidney Disease Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Chronic Kidney Disease Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Chronic Kidney Disease Drugs Revenue Forecast by Region (2021-2026)

3 Global Chronic Kidney Disease Drugs Competitor Landscape by Players
3.1 Global Top Chronic Kidney Disease Drugs Sales by Manufacturers
3.1.1 Global Chronic Kidney Disease Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Chronic Kidney Disease Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Chronic Kidney Disease Drugs Manufacturers by Revenue
3.2.1 Global Chronic Kidney Disease Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Chronic Kidney Disease Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Chronic Kidney Disease Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Chronic Kidney Disease Drugs Revenue in 2019
3.2.5 Global Chronic Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Chronic Kidney Disease Drugs Price by Manufacturers
3.4 Global Chronic Kidney Disease Drugs Manufacturing Base Distribution, Product Types
3.4.1 Chronic Kidney Disease Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chronic Kidney Disease Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Chronic Kidney Disease Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Chronic Kidney Disease Drugs Market Size by Type (2015-2020)
4.1.1 Global Chronic Kidney Disease Drugs Sales by Type (2015-2020)
4.1.2 Global Chronic Kidney Disease Drugs Revenue by Type (2015-2020)
4.1.3 Chronic Kidney Disease Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Chronic Kidney Disease Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Chronic Kidney Disease Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Chronic Kidney Disease Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Chronic Kidney Disease Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Chronic Kidney Disease Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Chronic Kidney Disease Drugs Market Size by Application (2015-2020)
5.1.1 Global Chronic Kidney Disease Drugs Sales by Application (2015-2020)
5.1.2 Global Chronic Kidney Disease Drugs Revenue by Application (2015-2020)
5.1.3 Chronic Kidney Disease Drugs Price by Application (2015-2020)
5.2 Chronic Kidney Disease Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Chronic Kidney Disease Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Chronic Kidney Disease Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Chronic Kidney Disease Drugs Price Forecast by Application (2021-2026)

6 China by Players, Type and Application
6.1 China Chronic Kidney Disease Drugs Market Size YoY Growth 2015-2026
6.1.1 China Chronic Kidney Disease Drugs Sales YoY Growth 2015-2026
6.1.2 China Chronic Kidney Disease Drugs Revenue YoY Growth 2015-2026
6.1.3 China Chronic Kidney Disease Drugs Market Share in Global Market 2015-2026
6.2 China Chronic Kidney Disease Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Chronic Kidney Disease Drugs Players by Sales (2015-2020)
6.2.2 China Top Chronic Kidney Disease Drugs Players by Revenue (2015-2020)
6.3 China Chronic Kidney Disease Drugs Historic Market Review by Type (2015-2020)
6.3.1 China Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
6.3.2 China Chronic Kidney Disease Drugs Revenue Market Share by Type (2015-2020)
6.3.3 China Chronic Kidney Disease Drugs Price by Type (2015-2020)
6.4 China Chronic Kidney Disease Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Chronic Kidney Disease Drugs Sales Forecast by Type (2021-2026)
6.4.2 China Chronic Kidney Disease Drugs Revenue Forecast by Type (2021-2026)
6.4.3 China Chronic Kidney Disease Drugs Price Forecast by Type (2021-2026)
6.5 China Chronic Kidney Disease Drugs Historic Market Review by Application (2015-2020)
6.5.1 China Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)
6.5.2 China Chronic Kidney Disease Drugs Revenue Market Share by Application (2015-2020)
6.5.3 China Chronic Kidney Disease Drugs Price by Application (2015-2020)
6.6 China Chronic Kidney Disease Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Chronic Kidney Disease Drugs Sales Forecast by Application (2021-2026)
6.6.2 China Chronic Kidney Disease Drugs Revenue Forecast by Application (2021-2026)
6.6.3 China Chronic Kidney Disease Drugs Price Forecast by Application (2021-2026)

7 North America
7.1 North America Chronic Kidney Disease Drugs Market Size YoY Growth 2015-2026
7.2 North America Chronic Kidney Disease Drugs Market Facts & Figures by Country
7.2.1 North America Chronic Kidney Disease Drugs Sales by Country (2015-2020)
7.2.2 North America Chronic Kidney Disease Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Chronic Kidney Disease Drugs Market Size YoY Growth 2015-2026
8.2 Europe Chronic Kidney Disease Drugs Market Facts & Figures by Country
8.2.1 Europe Chronic Kidney Disease Drugs Sales by Country
8.2.2 Europe Chronic Kidney Disease Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Chronic Kidney Disease Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Chronic Kidney Disease Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Chronic Kidney Disease Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Chronic Kidney Disease Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Chronic Kidney Disease Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Chronic Kidney Disease Drugs Market Facts & Figures by Country
10.2.1 Latin America Chronic Kidney Disease Drugs Sales by Country
10.2.2 Latin America Chronic Kidney Disease Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Chronic Kidney Disease Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Chronic Kidney Disease Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Chronic Kidney Disease Drugs Sales by Country
11.2.2 Middle East and Africa Chronic Kidney Disease Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Keryx Biopharmaceuticals, Inc
12.1.1 Keryx Biopharmaceuticals, Inc Corporation Information
12.1.2 Keryx Biopharmaceuticals, Inc Description and Business Overview
12.1.3 Keryx Biopharmaceuticals, Inc Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Products Offered
12.1.5 Keryx Biopharmaceuticals, Inc Recent Development
12.2 Kissei Pharmaceutical Co., Ltd
12.2.1 Kissei Pharmaceutical Co., Ltd Corporation Information
12.2.2 Kissei Pharmaceutical Co., Ltd Description and Business Overview
12.2.3 Kissei Pharmaceutical Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Products Offered
12.2.5 Kissei Pharmaceutical Co., Ltd Recent Development
12.3 AbbVie
12.3.1 AbbVie Corporation Information
12.3.2 AbbVie Description and Business Overview
12.3.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AbbVie Chronic Kidney Disease Drugs Products Offered
12.3.5 AbbVie Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Corporation Information
12.4.2 GlaxoSmithKline Description and Business Overview
12.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GlaxoSmithKline Chronic Kidney Disease Drugs Products Offered
12.4.5 GlaxoSmithKline Recent Development
12.5 Sanofi
12.5.1 Sanofi Corporation Information
12.5.2 Sanofi Description and Business Overview
12.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi Chronic Kidney Disease Drugs Products Offered
12.5.5 Sanofi Recent Development
12.6 F. Hoffmann-La Roche Ltd
12.6.1 F. Hoffmann-La Roche Ltd Corporation Information
12.6.2 F. Hoffmann-La Roche Ltd Description and Business Overview
12.6.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
12.6.4 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Products Offered
12.6.5 F. Hoffmann-La Roche Ltd Recent Development
12.7 Pfizer
12.7.1 Pfizer Corporation Information
12.7.2 Pfizer Description and Business Overview
12.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Pfizer Chronic Kidney Disease Drugs Products Offered
12.7.5 Pfizer Recent Development
12.8 AstraZeneca
12.8.1 AstraZeneca Corporation Information
12.8.2 AstraZeneca Description and Business Overview
12.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.8.4 AstraZeneca Chronic Kidney Disease Drugs Products Offered
12.8.5 AstraZeneca Recent Development
12.9 Amgen
12.9.1 Amgen Corporation Information
12.9.2 Amgen Description and Business Overview
12.9.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Amgen Chronic Kidney Disease Drugs Products Offered
12.9.5 Amgen Recent Development
12.10 Teva Pharmaceutical Industries
12.10.1 Teva Pharmaceutical Industries Corporation Information
12.10.2 Teva Pharmaceutical Industries Description and Business Overview
12.10.3 Teva Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Products Offered
12.10.5 Teva Pharmaceutical Industries Recent Development
12.11 Keryx Biopharmaceuticals, Inc
12.11.1 Keryx Biopharmaceuticals, Inc Corporation Information
12.11.2 Keryx Biopharmaceuticals, Inc Description and Business Overview
12.11.3 Keryx Biopharmaceuticals, Inc Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Products Offered
12.11.5 Keryx Biopharmaceuticals, Inc Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Chronic Kidney Disease Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Chronic Kidney Disease Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Chronic Kidney Disease Drugs Market Segments
Table 2. Ranking of Global Top Chronic Kidney Disease Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Chronic Kidney Disease Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of ACE Inhibitors
Table 5. Major Manufacturers of Calcium Channel Blockers
Table 6. Major Manufacturers of Beta Blockers
Table 7. Major Manufacturers of Others
Table 8. Global Chronic Kidney Disease Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Chronic Kidney Disease Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Chronic Kidney Disease Drugs Sales by Regions 2015-2020 (K MT)
Table 11. Global Chronic Kidney Disease Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Chronic Kidney Disease Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Chronic Kidney Disease Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 14. Global Chronic Kidney Disease Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 15. Global Chronic Kidney Disease Drugs Sales Share by Manufacturers (2015-2020)
Table 16. Global Chronic Kidney Disease Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Chronic Kidney Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Kidney Disease Drugs as of 2019)
Table 18. Chronic Kidney Disease Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Chronic Kidney Disease Drugs Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Chronic Kidney Disease Drugs Price (2015-2020) (USD/MT)
Table 21. Chronic Kidney Disease Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Chronic Kidney Disease Drugs Product Type
Table 23. Date of International Manufacturers Enter into Chronic Kidney Disease Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Chronic Kidney Disease Drugs Sales by Type (2015-2020) (K MT)
Table 26. Global Chronic Kidney Disease Drugs Sales Share by Type (2015-2020)
Table 27. Global Chronic Kidney Disease Drugs Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Chronic Kidney Disease Drugs Revenue Share by Type (2015-2020)
Table 29. Chronic Kidney Disease Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 30. Global Chronic Kidney Disease Drugs Sales Share by Type (2021-2026)
Table 31. Global Chronic Kidney Disease Drugs Sales by Application (2015-2020) (K MT)
Table 32. Global Chronic Kidney Disease Drugs Sales Share by Application (2015-2020)
Table 33. Global Chronic Kidney Disease Drugs Sales Share by Application (2021-2026)
Table 34. Global Chronic Kidney Disease Drugs Sales Market Share Forecast by Application (2021-2026)
Table 35. Global Chronic Kidney Disease Drugs Revenue by Application (2015-2020) (US$ Million)
Table 36. Global Chronic Kidney Disease Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 37. China Chronic Kidney Disease Drugs Sales (K MT) of Key Companies (2015-2020)
Table 38. China Chronic Kidney Disease Drugs Sales Share by Company (2015-2020)
Table 39. China Chronic Kidney Disease Drugs Revenue (US$ Million) by Company (2015-2020)
Table 40. China Chronic Kidney Disease Drugs Sales (K MT) by Type (2015-2020)
Table 41. China Chronic Kidney Disease Drugs Sales Share by Type (2015-2020)
Table 42. China Chronic Kidney Disease Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 43. China Chronic Kidney Disease Drugs Price (K MT) by Type (2015-2020)
Table 44. China Chronic Kidney Disease Drugs Sales (K MT) by Type (2021-2026)
Table 45. China Chronic Kidney Disease Drugs Sales Share by Type (2021-2026)
Table 46. China Chronic Kidney Disease Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 47. China Chronic Kidney Disease Drugs Revenue Share by Type (2021-2026)
Table 48. China Chronic Kidney Disease Drugs Price (K MT) by Type (2021-2026)
Table 49. China Chronic Kidney Disease Drugs Sales (K MT) by Application (2015-2020)
Table 50. China Chronic Kidney Disease Drugs Sales Share by Application (2015-2020)
Table 51. China Chronic Kidney Disease Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 52. China Chronic Kidney Disease Drugs Sales (K MT) by Application (2021-2026)
Table 53. China Chronic Kidney Disease Drugs Sales Share by Application (2021-2026)
Table 54. China Chronic Kidney Disease Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 55. China Chronic Kidney Disease Drugs Revenue Share by Application (2021-2026)
Table 56. North America Chronic Kidney Disease Drugs Sales by Country (2015-2020) (K MT)
Table 57. North America Chronic Kidney Disease Drugs Sales Market Share by Country (2015-2020)
Table 58. North America Chronic Kidney Disease Drugs Revenue by Country (2015-2020) (US$ Million)
Table 59. North America Chronic Kidney Disease Drugs Revenue Market Share by Country (2015-2020)
Table 60. Europe Chronic Kidney Disease Drugs Sales by Country (2015-2020) (K MT)
Table 61. Europe Chronic Kidney Disease Drugs Sales Market Share by Country (2015-2020)
Table 62. Europe Chronic Kidney Disease Drugs Revenue by Country (2015-2020) (US$ Million)
Table 63. Europe Chronic Kidney Disease Drugs Revenue Market Share by Country (2015-2020)
Table 64. Asia Pacific Chronic Kidney Disease Drugs Sales by Region (2015-2020) (K MT)
Table 65. Asia Pacific Chronic Kidney Disease Drugs Sales Market Share by Region (2015-2020)
Table 66. Asia Pacific Chronic Kidney Disease Drugs Revenue by Region (2015-2020) (US$ Million)
Table 67. Asia Pacific Chronic Kidney Disease Drugs Revenue Market Share by Region (2015-2020)
Table 68. Latin America Chronic Kidney Disease Drugs Sales by Country (2015-2020) (K MT)
Table 69. Latin America Chronic Kidney Disease Drugs Sales Market Share by Country (2015-2020)
Table 70. Latin Americaa Chronic Kidney Disease Drugs Revenue by Country (2015-2020) (US$ Million)
Table 71. Latin America Chronic Kidney Disease Drugs Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Chronic Kidney Disease Drugs Sales by Country (2015-2020) (K MT)
Table 73. Middle East and Africa Chronic Kidney Disease Drugs Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa Chronic Kidney Disease Drugs Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa Chronic Kidney Disease Drugs Revenue Market Share by Country (2015-2020)
Table 76. Keryx Biopharmaceuticals, Inc Corporation Information
Table 77. Keryx Biopharmaceuticals, Inc Description and Business Overview
Table 78. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Product
Table 80. Keryx Biopharmaceuticals, Inc Recent Development
Table 81. Kissei Pharmaceutical Co., Ltd Corporation Information
Table 82. Kissei Pharmaceutical Co., Ltd Description and Business Overview
Table 83. Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Kissei Pharmaceutical Co., Ltd Product
Table 85. Kissei Pharmaceutical Co., Ltd Recent Development
Table 86. AbbVie Corporation Information
Table 87. AbbVie Description and Business Overview
Table 88. AbbVie Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. AbbVie Product
Table 90. AbbVie Recent Development
Table 91. GlaxoSmithKline Corporation Information
Table 92. GlaxoSmithKline Description and Business Overview
Table 93. GlaxoSmithKline Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. GlaxoSmithKline Product
Table 95. GlaxoSmithKline Recent Development
Table 96. Sanofi Corporation Information
Table 97. Sanofi Description and Business Overview
Table 98. Sanofi Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Sanofi Product
Table 100. Sanofi Recent Development
Table 101. F. Hoffmann-La Roche Ltd Corporation Information
Table 102. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 103. F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. F. Hoffmann-La Roche Ltd Product
Table 105. F. Hoffmann-La Roche Ltd Recent Development
Table 106. Pfizer Corporation Information
Table 107. Pfizer Description and Business Overview
Table 108. Pfizer Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Pfizer Product
Table 110. Pfizer Recent Development
Table 111. AstraZeneca Corporation Information
Table 112. AstraZeneca Description and Business Overview
Table 113. AstraZeneca Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. AstraZeneca Product
Table 115. AstraZeneca Recent Development
Table 116. Amgen Corporation Information
Table 117. Amgen Description and Business Overview
Table 118. Amgen Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Amgen Product
Table 120. Amgen Recent Development
Table 121. Teva Pharmaceutical Industries Corporation Information
Table 122. Teva Pharmaceutical Industries Description and Business Overview
Table 123. Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Teva Pharmaceutical Industries Product
Table 125. Teva Pharmaceutical Industries Recent Development
Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 127. Key Challenges
Table 128. Market Risks
Table 129. Main Points Interviewed from Key Chronic Kidney Disease Drugs Players
Table 130. Chronic Kidney Disease Drugs Customers List
Table 131. Chronic Kidney Disease Drugs Distributors List
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Chronic Kidney Disease Drugs Product Picture
Figure 2. Global Chronic Kidney Disease Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. ACE Inhibitors Product Picture
Figure 4. Calcium Channel Blockers Product Picture
Figure 5. Beta Blockers Product Picture
Figure 6. Others Product Picture
Figure 7. Global Chronic Kidney Disease Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Hospitals
Figure 9. Specialty Clinics
Figure 10. Chronic Kidney Disease Drugs Report Years Considered
Figure 11. Global Chronic Kidney Disease Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Chronic Kidney Disease Drugs Sales 2015-2026 (K MT)
Figure 13. Global Chronic Kidney Disease Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Chronic Kidney Disease Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Chronic Kidney Disease Drugs Sales Market Share by Region in 2019
Figure 16. Global Chronic Kidney Disease Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Chronic Kidney Disease Drugs Revenue Market Share by Region in 2019
Figure 18. Global Chronic Kidney Disease Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Chronic Kidney Disease Drugs Revenue in 2019
Figure 20. Chronic Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Chronic Kidney Disease Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Chronic Kidney Disease Drugs Sales Market Share by Type in 2019
Figure 23. Global Chronic Kidney Disease Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Chronic Kidney Disease Drugs Revenue Market Share by Type in 2019
Figure 25. Global Chronic Kidney Disease Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Chronic Kidney Disease Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Chronic Kidney Disease Drugs Sales Market Share by Application in 2019
Figure 28. Global Chronic Kidney Disease Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Chronic Kidney Disease Drugs Revenue Market Share by Application in 2019
Figure 30. China Chronic Kidney Disease Drugs Sales Growth Rate 2015-2026 (K MT)
Figure 31. China Chronic Kidney Disease Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 32. China Chronic Kidney Disease Drugs Market Share in Global Market 2015-2026
Figure 33. China 5 and 10 Largest Chronic Kidney Disease Drugs Players Market Share by Revenue in Chronic Kidney Disease Drugs in 2019
Figure 34. China Chronic Kidney Disease Drugs Revenue Share by Type (2015-2020)
Figure 35. China Chronic Kidney Disease Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 36. China Chronic Kidney Disease Drugs Revenue Share by Application (2015-2020)
Figure 37. China Chronic Kidney Disease Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 38. North America Chronic Kidney Disease Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 39. North America Chronic Kidney Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. North America Chronic Kidney Disease Drugs Sales Market Share by Country in 2019
Figure 41. North America Chronic Kidney Disease Drugs Revenue Market Share by Country in 2019
Figure 42. U.S. Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 43. U.S. Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Canada Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 45. Canada Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. Europe Chronic Kidney Disease Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 47. Europe Chronic Kidney Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Chronic Kidney Disease Drugs Sales Market Share by Country in 2019
Figure 49. Europe Chronic Kidney Disease Drugs Revenue Market Share by Country in 2019
Figure 50. Germany Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Germany Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. France Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 55. U.K. Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 57. Italy Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 59. Russia Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Asia Pacific Chronic Kidney Disease Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 61. Asia Pacific Chronic Kidney Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Chronic Kidney Disease Drugs Sales Market Share by Region in 2019
Figure 63. Asia Pacific Chronic Kidney Disease Drugs Revenue Market Share by Region in 2019
Figure 64. China Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 65. China Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. Japan Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. South Korea Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. India Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. Australia Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Taiwan Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Indonesia Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Thailand Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Malaysia Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 83. Philippines Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 85. Vietnam Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Latin America Chronic Kidney Disease Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Chronic Kidney Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Chronic Kidney Disease Drugs Sales Market Share by Country in 2019
Figure 89. Latin America Chronic Kidney Disease Drugs Revenue Market Share by Country in 2019
Figure 90. Mexico Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Middle East and Africa Chronic Kidney Disease Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Chronic Kidney Disease Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Chronic Kidney Disease Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Chronic Kidney Disease Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Chronic Kidney Disease Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Chronic Kidney Disease Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Porter's Five Forces Analysis
Figure 107. Chronic Kidney Disease Drugs Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3900
USD $5850
USD $7800
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.